SKI Market

Indian Indices

Sensex

81,857.48 319.78
( 0.39%)

Global Indices

Nasdaq

49,444.50 324.78
(0.66%)

Dow Jones

6,973.05 36.44
(0.53%)

Hang Seng

53,322.83 437.58
(0.83%)

Nikkei 225

10,215.77 66.92
(0.66%)

Forex

USD-INR

91.64 0.05
(0.06%)

EUR-INR

108.40 1.13
(1.05%)

GBP-INR

125.02 1.82
(1.48%)

JPY-INR

0.59 0.01
(1.89%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Natco Pharma concludes USFDA inspection of its API unit in Chennai

Nov 21,2025

Natco Pharma today announced conclusion of US FDA Inspection at its Manali, Chennai, Active Pharmaceutical Ingredients (API) Unit. The inspection was conducted from 17 - 21 November 2025.

On conclusion of the inspection, the Company received seven observations in the Form-483. The Company believes that the observations are procedural in nature. The Company is confident to address these observations comprehensively.

81,857.48 319.78 ( 0.39%)

49,444.50 324.78 (0.66%)

6,973.05 36.44 (0.53%)

53,322.83 437.58 (0.83%)

10,215.77 66.92 (0.66%)

91.64 0.05 (0.06%)

108.40 1.13 (1.05%)

125.02 1.82 (1.48%)

0.59 0.01 (1.89%)